Skip to content
★ Sign in to follow
DXS International PLC logo

DXS International PLC Stock: price and insider trades · United Kingdom

ISIN GB00B2Q6HZ92GB·Mcap £960.3kHealth Care

No insider purchase over the last 90 days. The latest, by Mr. Robert Sutcliffe, was filed 14 Feb 2025.

DXS International PLC: what insiders have been doing

This page follows insider dealings at DXS International PLC as filed with RNS (LSE), a company from the Health Care sector. Nothing new has been filed by managers of DXS International PLC in twelve months, the latest record being from 14 February 2025.

Our records for DXS International PLC go back to 2020, with 14 purchases and no sales on the open market in total.

Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Insider Decl.
17
Thresholds
n/a
Buy Volume
€117,515
14 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Robert Sutcliffe5 buys

Since the insiders bought

  • Filed 14 Feb 2025 · 632 days ago · €1,039
    -28.6%
    Entry £0.00 · Close at T+365 £0.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 8,785 of 26,912 companies
60.2
score / 100
Value
57
Quality
64
FCF yld41%
Earn yld-9.9%
EV/EBITDA·
ROE15%
Gross mgn86%
Net mgn-2.7%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended April 2025 · cache

£0.00
Analyst consensus
0.00/5
Income statement
Revenue£3.5M
Gross profit£3M86% margin
EBITDA-£125.6k-4% margin
Net income-£94.8k1.9% margin
Valuation
P/Book75.0x
Beta0.84
Balance sheet & cash
Market cap£960.3k
Total debt£470.2k
Free Cash Flow£396.2k
Debt / Equity66%
Profitability & ownership
ROE14.6%
ROA-1.6%
% insiders47.2%
% institutions10.7%
Last declaration on 14 February 2025
Declarations17 total
  • ▲
    ChairmanExecutives
    867 GBP8RNS
    30,000 shares@ £0.028914.3% of flowAquis Stock ExchangeRNS:1001048499-en
    Canonical exit: 14 May 2025 (T+90)
  • ▲
    ChairmanExecutives
    867 GBP8RNS
    30,000 shares@ £0.028914.3% of flowAquis Stock ExchangeRNS:1001047580-en
    Canonical exit: 8 May 2025 (T+90)
  • ▲
    ChairmanExecutives
    700 GBP8RNS
    20,000 shares@ £0.03511.5% of flowAquis Stock ExchangeRNS:1001046237-en
    Canonical exit: 1 May 2025 (T+90)
  • ▲
    ChairmanExecutives
    435 GBP8RNS
    15,000 shares@ £0.0297.1% of flowAquis Stock ExchangeRNS:1001045891-en
    Canonical exit: 30 Apr 2025 (T+90)
  • ▲
    ChairmanExecutives
    0RNS
    0Aquis Stock ExchangeRNS:1001044786-en
    Canonical exit: 24 Apr 2025 (T+90)
  • ▲
    ChairmanExecutives
    455 GBP8RNS
    35,000 shares@ £0.0137.5% of flowAquis Stock ExchangeRNS:1001012240-en
    Canonical exit: 4 Feb 2025 (T+90)
  • ▲
    ChairmanExecutives
    2,750 GBP12RNS
    183,333 shares@ £0.01545.4% of flowAquis Stock ExchangeRNS:1001010704-en
    Canonical exit: 28 Jan 2025 (T+90)
  • ●
    ChairmanExecutives
    1,460 GBP9RNS
    100,000 shares@ £0.014624.6% of flowAquis Stock ExchangeRNS:1000948378-en
  • ●
    Chief ExecutiveExecutives
    1,000 GBP30RNS
    40,000 shares@ £0.025100.0% of flowAquis Stock ExchangeRNS:1000902759-en
  • ●
    ChairmanExecutives
    4,500 GBP15RNS
    180,000 shares@ £0.02575.4% of flowAquis Stock ExchangeRNS:1000902757-en
  • ▲
    Chief ExecutiveExecutives
    2,732 GBP0FCA-NSM
    50,084 shares@ £0.0545AQSEISIN GB00B2Q6HZ92FCA-NSM:1000768240-en
    Canonical exit: 16 Feb 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    84,500 GBP0FCA-NSM
    845,000 shares@ £0.10Outside a trading venueISIN GB00B2Q6HZ92FCA-NSM:1000660387-en
    Canonical exit: 4 Sept 2022 (T+90)
  • ▲
    ChairmanExecutives
    1,300 GBP0FCA-NSM
    10,156 shares@ £0.128AQSEISIN GB00B2Q6HZ92FCA-NSM:1000533235-en
    Canonical exit: 21 Nov 2021 (T+90)
  • ▲
    ChairmanExecutives
    1,000 GBP0FCA-NSM
    13,333 shares@ £0.075AQSEISIN GB00B2Q6HZ92FCA-NSM:1000445200-en
    Canonical exit: 10 Mar 2021 (T+90)
  • ▲
    ChairmanExecutives
    1,000 GBP0FCA-NSM
    14,814 shares@ £0.0675AQSEISIN GB00B2Q6HZ92FCA-NSM:1000433899-en
    Canonical exit: 20 Jan 2021 (T+90)
  • ▲
    ChairmanExecutives
    1,000 GBP0FCA-NSM
    14,534 shares@ £0.0688AQSEISIN GB00B2Q6HZ92FCA-NSM:1000430220-en
    Canonical exit: 29 Dec 2020 (T+90)
  • ▲
    ChairmanExecutives
    3,000 GBP0FCA-NSM
    46,153 shares@ £0.065AQSEISIN GB00B2Q6HZ92FCA-NSM:1000368614-en
    Canonical exit: 18 Oct 2020 (T+90)

17 of 17 declarations

About DXS International PLC

DXS International PLC is a company listed on the London market, specializing in digital health solutions. It focuses on improving access to healthcare through technology.